Shopping News / Articles
Around the Helix: Cell and Gene Therapy Company Updates " April 8, 2026
6+ hour, 44+ min ago (249+ words) Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies. The cell and gene therapy sectors are growing exponentially, with new players emerging daily and much progress being made both in…...
Around the Helix: Cell and Gene Therapy Company Updates " April 1, 2026
1+ week, 13+ hour ago (220+ words) Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies. The cell and gene therapy sectors are growing exponentially, with new players emerging daily and much progress being made both in…...
Around the Helix: Cell and Gene Therapy Company Updates " March 25, 2026
2+ week, 7+ hour ago (226+ words) Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies. The cell and gene therapy sectors are growing exponentially, with new players emerging daily and much progress being made both in…...
Guess the Therapy Answer March 18, 2026
2+ week, 5+ day ago (186+ words) Sangamo Starts Putting BLA for Fabry Disease Gene Therapy Isa-Vec in Front of FDA December 19, 2025 " Sangamo Therapeutics has begun submission of a rolling biologics license application (BLA) application to the FDA for investigational Fabry disease gene therapy isaralgagene civaparvove (isa-vec,…...
Angela Lek, Ph D, on the Scientific Priorities that Shaped the 2026 MDA Conference
2+ week, 5+ day ago (198+ words) The chief research officer of the Muscular Dystrophy Association discussed highlights and themes from the organization's 2026 Clinical and Scientific Conference. Lek also touched on drug development access and economics, noting that of the 300-plus conditions MDA covers, the majority are…...
Jerel A. Banks, MD, Ph D, on Evaluating Gene Therapy BB-301 for OPMD-Related Dysphagia
3+ week, 5+ day ago (169+ words) The CEO of Benitec Biopharma discussed data he presented at MDA's 2026 conference. Banks emphasized that given the progressive nature of OPMD-related swallowing impairment, functional improvements could carry meaningful clinical impact by reducing aspiration risk. He also discussed future plans for…...
John F. Crowley, JD, MBA, on the Future of Neuromuscular Care
4+ week, 10+ hour ago (145+ words) The president and chief executive officer of the Biotechnology Innovation Organization discussed insights from his keynote address at MDA's 2026 conference. Stay at the forefront of cutting-edge science with CGT'your direct line to expert insights, breakthrough data, and real-time coverage of…...
Around the Helix: Cell and Gene Therapy Company Updates " March 4, 2026
1+ mon, 4+ day ago (248+ words) Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies. The cell and gene therapy sectors are growing exponentially, with new players emerging daily and much progress being made both in…...
Practical Considerations for Implementing SCD Gene Therapy Into Clinical Use
1+ mon, 5+ day ago (175+ words) Robin E. Miller, MD, director of the Sickle Cell Disease Program at Nemours Children's Hospital, discussed what clinics need in order to start administering gene therapy effectively. We are bringing our transplant and cellular therapies team in to talk with the…...
The potential of bringing hemophilia B gene therapy to younger patients
1+ mon, 5+ day ago (11+ words) CGTLive...
Shopping
Please enter a search for detailed shopping results.